The fund’s primary objective is to provide the opportunity for investors to take part in the European Equity Markets and achieve capital gains in the long run through diversified Shariah Compliant Equities. The equities are constituent on the Dow Jones Islamic Market Index Titan 100. The fund’s performance is measured against the Dow Jones Islamic Titans 100 benchmark. The fund reinvests its income earned within the fund and therefore it will be reflected in the net asset value of the units.
AlJazira European Equities Fund
Latest Price NAV
USD
194.20
as of
11/Sep/23
Objective
Performance
3 Yrs Performance
3.67
5 Yrs Performance
4.36
10 Yrs Performance
4.72
Top Holdings
1.
Novo-Nordisk Asdkk0.2 Se
7.09
%
2.
Asml Holding Nveur0.09
5.36
%
3.
Novartis Ag Chf0.50 (Regd)
4.74
%
4.
Roche Holdings Aggenussc
4.47
%
5.
Astrazeneca Ordusd0.25
4.34
%
6.
Nestle Sachf0.10(Regd)
3.7
%
7.
L'Oreal Eur0.20
3.08
%
8.
Gsk Plc
2.51
%
9.
Sap Se
2.36
%
10.
Unilever Plc Ordgbp 0.03
2.03
%
Portfolio Composition
1.
Switzerland
22.24
%
2.
United Kingdom
17.57
%
3.
France
16.57
%
4.
Netherlands
11.1
%
5.
Denmark
8.82
%
6.
Germany
8
%
7.
Sweden
6.97
%
8.
Spain
3.46
%
9.
Others
3.46
%
10.
Italy
1.82
%
Transaction Information
Annual Charges
Minimum Charge :
N.A
Maximum Charge:
N.A
Actual Charge :
1.5
Initial Charges
Minimum Charge :
N.A
Maximum Charge :
2
Actual Charge :
N.A
Redemption Charges
Minimum Charge :
N.A
Maximum Charge:
N.A
Actual Charge :
N.A
Contact
Company Name:
Aljazira Capital
Website :
http://www.aljaziracapital.com.sa